Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Change in Accured Expenses (2016 - 2025)

MedWellAI (MWAI) has disclosed Change in Accured Expenses for 11 consecutive years, with $13694.0 as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 57.37% to $13694.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $17308.0, a 78.44% decrease, with the full-year FY2025 number at $35205.0, down 56.74% from a year prior.
  • Change in Accured Expenses was $13694.0 for Q4 2025 at MedWellAI, up from $13309.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $55888.0 in Q3 2022 to a low of -$25554.0 in Q2 2025.
  • A 5-year average of $15336.7 and a median of $13501.5 in 2025 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: soared 21134.62% in 2023, then tumbled 302.18% in 2025.
  • MedWellAI's Change in Accured Expenses stood at -$1665.0 in 2021, then soared by 3456.64% to $55888.0 in 2022, then plummeted by 58.85% to $23000.0 in 2023, then surged by 39.66% to $32122.0 in 2024, then tumbled by 57.37% to $13694.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Change in Accured Expenses are $13694.0 (Q4 2025), $13309.0 (Q3 2025), and -$25554.0 (Q2 2025).